ICTI News
Interactive Clinical Technologies Incorporated (ICTI) is pleased to announce that it recently successfully completed implementation of a Storage Area Network (SAN).
Yardley, PA -- May 5, 2005 - Interactive Clinical Technologies Incorporated (ICTI) is pleased to announce that it recently successfully completed implementation of a Storage Area Network (SAN). The SAN is but one component of ICTI's High Availability Strategy.
Putting ICTI at the forefront of the IVRS and EDC markets, the SAN provides full state-of-the-art backup and disaster recovery for ICTI's clients. By maintaining a complete copy of all of ICTI's data in a geographically separate, secure location, the SAN ensures the integrity of clients' data in the case of a disaster. Data are written to the SAN in real time so that, unlike commonly used data backup procedures, there is no loss of data at ICTI in the event that ICTI's main location is damaged and/or unavailable.
The SAN has massive capacity, not being limited in scalability or performance in the way that local area networks are. It also increases the efficiency of system resources, leaving more system resources available for clients' applications.
Our clients' clinical systems auditors in particular appreciate the data protection provided by the high reliability and high performance of ICTI's fully validated SAN implementation.
Fritz Haas, ICTI's Vice President of Information Systems, reflected, "While the implementation of the SAN was a technology project, the impetus behind it was our commitment to complete customer satisfaction. That commitment means that we need to provide 100% data security and reliability. The SAN, along with our robust network environment, provides clients with that security."
About ICTI and Almac Sciences
ICTI is a division of Almac Sciences that specializes in interactive solutions to accelerate the clinical trials process and reduce the costs of clinical trials. Our solutions include Interactive Voice Response (iVR) for patient randomization, dosing and clinical supply management; phone-based patient diaries; iTrial EDC for clinical trials data; and forecasting for clinical trials supplies planning.
Almac Sciences and its affiliated companies (CSS (Chemical Synthesis Services), CTS (Clinical Trial Services), ICTI (Interactive Clinical Technologies Incorporated), PDMS (Pharmaceutical Development and Manufacturing Services) and ArraDx (Array Based Diagnostics)) provide a broad range of services across drug discovery, diagnostics, pharmaceutical research and development, manufacture of API, clinical trials and drug product manufacture. US operations are based in Pennsylvania, North Carolina and California. European operations are headquartered in Craigavon, Northern Ireland with additional operations in London and Edinburgh.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
